Navigation Links
2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event
Date:9/30/2008

ther to learn from the experts, and implementing the results of their research, knowledge and experience, we should finally be able to achieve comprehensive early identification and effective intervention.

Confirmed presenters and title of their presentations include

Early Identification:

  • Pauline A. Filipek MD,
  • Typical and Atypical Infant Development: When Should We Be Concerned?
  • Mel Rutherford, Ph.D.
  • Differences in Social Perceptual Development Allow for Autism Screening in the First Year of Life
  • Mary Beth Steinfeld, M.D.
  • Identification of Autism Before Two Years of Age
  • Jennifer Pinto Martin, Ph.D.
  • Screening Strategies for Autism Spectrum Disorder
  • Karen Pierce, Ph.D.,
  • The Early Identification of Autism: Towards a Bio-Behavioral Approach
  • Lori Annes, Ph.D.,P.T., Mary Beth Steinfeld, M.D., Douglas Vanderbilt, M.D., Janis White, Ed.D.: Panel: What are the Hurdles from Positive Screen to Early Intervention

Early Intervention:

  • Barbara Kalmanson, Ph.D. & Janet Green Babb, M.S., P.T.
  • Insights for Infant-Parent Treatment of Early Signs of Autistic Spectrum Disorder
  • Paula Horner, Phc.D., CCC-SLP
  • Social Reciprocity in the Infant-Parent Dyad: Implications for Early Social Communicative Intervention in Autism
  • Laurie Vismara, Ph.D., BCBA
  • Can One Hour per Week of Therapy Lead to Lasting Changes in Young Children with Autism?
  • Tracey Stackhouse, M.A., O.T.R.
  • The Role of the Occupational Therapist in Early Identification and Intervention for Autism Spectrum Disorders
  • Hanna Alonim
  • A Window of Opportunity: Detection and Treatment of Infants with Early Signs of Autism

    '/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Modular Building Systems International (MBSI) Supplies Buildings For First Platinum Certified Green Modular School In The U.S.
2. MD2 International Brings Highly Attentive Medicine to Chicago
3. Block Imaging International, Inc. Partners with Dicom Solutions, Inc. to Offer New Products
4. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
5. Internationally adopted children hit puberty earlier
6. CHF International: Haiti Needs Your Help
7. Kabul Under Virtual Lockdown for International Travelers, Progress Still Evident for Women's Programs
8. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
9. Clements International Develops Insurance for Medical Tourism Industry
10. The SCOOTER Store Recognized by Runzheimer International for Third Year
11. Two U.S. Researchers Win Prestigious International Science Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... debunks the ,something,s wrong with being single, myth , , SATURDAY, ... who pass their 40th birthday without ever tying the knot, ... woes than married folks. And, um, isn,t there something wrong ... fast. , A new study looking at psychological measures shows ...
(Date:12/4/2009)... Systems (NYSE: VAR ) announced today that its ... of Stockholders for February 11, 2010 with a record date ... the Crowne Plaza Cabana Hotel, 4290 El Camino Real, Palo ... be webcast by Thomson Financial and can be accessed at ...
(Date:12/4/2009)... The American Association of Homes and Services for the Aging ... Living and Supportive Services (CLASS) provisions remain in the final ... providing support to elders, people with disabilities and their caregivers. ... care reform bill that will make it affordable to care ...
(Date:12/4/2009)... While Congress debates whether health care reform ... point to 45 hospitals that lead through example ... nation while attaining the highest levels of efficiency. ... have been named 2009 Leapfrog Top Hospitals, based ...
(Date:12/4/2009)... Western Reserve University researchers, from the School of Medicine,s ... which products of lipid peroxidation and some drugs of ... identified by a combination of metabolomics and mass isotopomer ... of action of the drug of abuse gamma-hydroxybutyrate, also ...
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
... the pharmaceutical Antifoam (Simethicone) business from Bluestar Silicones. , ... ... -- NuSil Technology ( http://www.nusil.com ), a leading formulator and ... announced a definitive agreement to acquire the pharmaceutical Antifoam (Simethicone) ...
... Sleep apnea has long been known to be associated with ... issue of Diabetes Care finds that the disorder ... nearly 87 percent of participants reported symptoms, but were ... doesn,t just mean their sleep is disrupted; existing research shows ...
... following is a statement of Matthew L. Myers, ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) The Campaign for Tobacco-Free ... his leadership role in Senate committee approval of ... Administration (FDA) regulatory authority over tobacco products, including ...
... Smart Balance, Inc. (Nasdaq: SMBL ) today held ... and CEO Stephen Hughes spoke to stockholders about the Company,s ... past year, consumers have found Smart Balance,s brand proposition compelling ... category of spreads," Hughes said. "We are excited as ...
... communities in outstate Minnesota MINNEAPOLIS, May 20 ... regional grants dedicated to reducing tobacco,s harm through ... grants will provide resources to communities outside the ... our continuing commitment to reducing tobacco,s harm and ...
... the Archdiocese of Boston may soon refer women ... Centene Corp. and archdiocese-run Caritas Christi Health Care.(Logo: ... over the impact of nationalized health care on ... to ethically compromise with a potential federal health ...
Other Medicine News:Health News:NuSil Technology Acquires Pharmaceutical Antifoam (Simethicone) Business from Bluestar Silicones 2Health News:NuSil Technology Acquires Pharmaceutical Antifoam (Simethicone) Business from Bluestar Silicones 3Health News:More than a bad night's sleep 2Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 2Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 3Health News:ClearWay Minnesota(SM) Board Approves Four Regional Grants 2Health News:ALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture 2
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
(Date:12/3/2009)... YORK, Dec. 3 Guidepoint Global, LLC , a ... Sleep Apnea Tracker, a monthly longitudinal data release that monitors ... Apnea market. ,, The Sleep Apnea Tracker captures actual ... in the United States from 15 different equipment providers going ...
(Date:12/3/2009)... Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ... innovative small molecule drugs for the treatment of immune ... host a webcast and conference call on, Tuesday, December ... and 8:00am Pacific Time) to discuss clinical data regarding ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Smart Balance Announces 2009 Second Quarter Results 53838 1Smart Balance Announces 2009 Second Quarter Results 53838 2Smart Balance Announces 2009 Second Quarter Results 53838 3Smart Balance Announces 2009 Second Quarter Results 53838 4Smart Balance Announces 2009 Second Quarter Results 53838 5Smart Balance Announces 2009 Second Quarter Results 53838 6Smart Balance Announces 2009 Second Quarter Results 53838 7Smart Balance Announces 2009 Second Quarter Results 53838 8Smart Balance Announces 2009 Second Quarter Results 53838 9Smart Balance Announces 2009 Second Quarter Results 53838 10Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 1Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 2Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 3
... This Patient ... Population -, ... and Bristol-Myers Squibb Company (NYSE: BMY ),announced today that the ... for ABILIFY(R) (aripiprazole) for the,acute treatment of manic and mixed episodes ...
... 275 residents screened for HIV during three testing days ... of,February, Test for Life worked with the Washington Wizards, ... Washington, DC,to offer free and confidential HIV testing to ... at the Temple of Praise,Whitman-Walker and Us Helping Us ...
Other Medicine Technology:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 2U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 3U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 4U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 5U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 6U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 7U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 8U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 9Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS 2
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring core temperature and heart and breath sounds....
... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
... Level 1 enables ... multiparameter patient monitors to ... series. Our temperature monitoring ... cables are superior in ...
Medicine Products: